Glenmede Trust CO Na Oramed Pharmaceuticals Inc. Transaction History

Glenmede Trust CO Na

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$2.48 - $4.64 $22,429 - $41,964	-9,044 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$2.58 - $4.16 $2,466 - $3,976	-956 Reduced 9.56%	9,044 $23,000
Q4 2019 Feb 12, 2020	SELL	$2.43 - $5.74 $24,300 - $57,400	-10,000 Reduced 50.0%	10,000 $51,000
Q3 2017 Nov 14, 2017	BUY	$7.74 - $10.78 $154,800 - $215,600	20,000	20,000 $0

7.4M

2.1K

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $92.4M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.